ChartMill assigns a Buy % Consensus number of 43% to PMCB. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-11-08 | HC Wainwright & Co. | Initiate | Neutral |
The consensus rating for PHARMACYTE BIOTECH INC (PMCB) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.